Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Retinitis Pigmentosa

Pharmaceuticals

RetroSense Gets Patent On Method for Restoring Vision

ANN ARBOR — The Ann Arbor-based biopharmaceutical startup RetroSense Therapeutics LLC announced that the United States Patent and Trademark Office has granted U.S. patent Application No. 11,036,629, entitled “Method for …

Pharmaceuticals

RetroSense Doses First Patient In Test Of Blindness Drug

ANN ARBOR —  The pharmaceutical startup RetroSense Therapeutics LLC Monday announced the first patient in a Phase I/IIa clinical trial of its lead drug candidate, RST-001. The drug is designed …

Health Care / Pharmaceuticals

RetroSense Raises $6M In Over-Subscribed Funding Round

ANN ARBOR — RetroSense Therapeutics, a privately held, clinical-stage biopharmaceutical company, announced that it has secured $6 million in a Series B financing to further investigate the use of gene …

Pharmaceuticals

RetroSense Gene Therapy Drug Gets FDA OK For Human Trials

ANN ARBOR — The pharmaceutical startup RetroSense Therapeutics LLC said Monday that its Investigational New Drug application for its lead drug candidate, RST-001, has received clearance from the United States …

Biotech

RetroSense Therapeutics Finalist For Angel Award

ANN ARBOR — RetroSense Therapeutics LLC, the Ann Arbor pharma startup, said it had been selected as a finalist for the Luis Villalobos Award, sponsored by the Angel Capital Association. …

Health Care / Pharmaceuticals

RetroSense Raises $6M To Develop Retinitis Pigmentosa Drug

ANN ARBOR — The privately held biopharmaceutical company RetroSense Therapeutics said Thursday it had raised $6 million in Series A financing to investigate the use of gene therapy and optogenetics …

Health Care / Life Sciences

RetroSense Gets Intellectual Property Deal

ANN ARBOR — The Ann Arbor biopharmaceutical startup RetroSense Therapeutics announced a license agreement for exclusive, worldwide rights to Massachusetts General Hospital’s patent application entitled “Method for Augmenting Vision in …

Life Sciences

Ann Arbor Firm Gets Orphan Drug Status For RP Treatment

ANN ARBOR — Ann Arbor-based RetroSense Therapeutics LLC said it had received “orphan drug” status from the federal Food and Drug Administration for its lead drug candidate, RST-001, intended to …

Read the magazine:

TechCentury
Advertise or Contribute an Article
Lawrence Technological University

Subscribe to TechCentury.com

Top Posts

  • Meijer adds 'Shop & Scan' technology
  • Liquid Web Bought Out By Chicago Firm; Founding CEO To Step Down
  • ESD Spring Engineering & Tech Job Fair Drawing A Big Crowd
  • Presentations sought for INCOSE conference
  • Kraig Biocraft shareholders OK reverse stock split, uplisting to national exchange

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT